National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Brawley, OW; Cornelius, LJ; Edwards, LR; Gamble, VN; Green, BL; Inturrisi, C; James, AH; Laraque, D; Mendez, M; Montoya, CJ; Pollock, BH; Robinson, L; Scholnik, AP; Schori, M

Published Date

  • June 17, 2008

Published In

Volume / Issue

  • 148 / 12

Start / End Page

  • 932 - 938

PubMed ID

  • 18458271

Pubmed Central ID

  • 18458271

Electronic International Standard Serial Number (EISSN)

  • 1539-3704

Digital Object Identifier (DOI)

  • 10.7326/0003-4819-148-12-200806170-00220

Language

  • eng

Conference Location

  • United States